Market revenue in 2024 | USD 84.4 million |
Market revenue in 2030 | USD 93.1 million |
Growth rate | 1.6% (CAGR from 2025 to 2030) |
Largest segment | Conventional |
Fastest growing segment | Molecular |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Molecular, Conventional |
Key market players worldwide | BioMerieux SA, Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG ADR, Becton Dickinson & Co, Qiagen NV, Thermo Fisher Scientific Inc, Meridian Bioscience, Hologic, Inc. |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hospital acquired infections diagnostics market will help companies and investors design strategic landscapes.
Conventional was the largest segment with a revenue share of 54.38% in 2024. Horizon Databook has segmented the South Korea hospital acquired infections diagnostics market based on molecular, conventional covering the revenue growth of each sub-segment from 2018 to 2030.
In South Korea, the market is highly competitive and technologically advanced, driven by a strong focus on innovation and high adoption of molecular diagnostics. Key players include global giants and local firms such as Seegene and SD Biosensor, which have pioneered innovations in multiplex molecular diagnostics.
The South Korean market benefits from government-funded research initiatives that promote the development of HAI diagnostic tools, with a particular emphasis on solutions for antimicrobial resistance detection.
South Korea has a robust regulatory system overseen by the Ministry of Food and Drug Safety (MFDS). The country has stringent guidelines for diagnostic device approval, with a clear pathway for clinical trials, post-market surveillance, and quality control. South Korea is proactive in addressing challenges such as antimicrobial resistance by fast-tracking innovative HAI diagnostic tools.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea hospital acquired infections diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into South Korea hospital acquired infections diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account